Head of Department
Erasmus MC
Rotterdam, Netherlands
Frank Leebeek obtained his medical degree and PhD degree at the Erasmus University in Rotterdam The Netherlands in 1990. He subsequently worked as a post-doctoral fellow for 2 years at the University of North Carolina at Chapel Hill, USA. He was trained as a haematologist at the Erasmus University Medical Center in Rotterdam, where he became a staff member and was appointed full professor in 2009. He is chair of the Department of Haematology since 2017. He is coordinating a research team on haemostasis and thrombosis with several research topics, mainly inherited bleeding disorders, including von Willebrand disease and haemophilia. He is steering committee member of several studies on new treatments for patients with bleedings disorders, including gene therapy. He is also the principal investigator of the Willebrand in the Netherlands (WiN) study and the WiN-Pro study.
He has been secretary of the Dutch Society of Thrombosis and Haemostasis, chairman of the Dutch Hemophilia Doctor’s Organisation, and is currently a board member of the Dutch Society of Haematology and the European Hematology Association. He has been co-chair of the Scientific and Standardization Committee on von Willebrand Factor of the International Society on Thrombosis and Haemostasis. Dr Leebeek has (co-)authored over 400 scientific publications listed on PubMed, 20 book chapters and contributed to national and international treatment guidelines on haemophilia, von Willebrand’s disease and venous thrombosis.